CASI Pharmaceuticals Inc
CASI Pharmaceuticals Inc (CASI) is known on NASDAQ - China, but Bullrun does not have financial statement history attached to this listing yet.
Key Metrics
- TickerCASI
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Financial periodQ3 2025
- RevenueUSD 3.08M
- Net income-USD 10.88M
- Gross margin23.0%